Voting Rights Announcements | 14 February 2017 15:47

Evotec AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Evotec AG

14.02.2017 / 15:47
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer

Evotec AG
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany

2. Reason for notification

X	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
	Change of breakdown of voting rights
X	Other reason: Voluntary group notification with triggered threshold on subsidiary level

3. Details of person subject to the notification obligation

Name:	City and country of registered office:
Novo Nordisk Fonden	Hellerup Denmark

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.

Novo A/S

5. Date on which threshold was crossed or reached

13 Feb 2017

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation	8.99 %	0 %	8.99 %	146,217,093
Previous notification	n/a %	n/a %	n/a %	/

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN	absolute		in %
	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)
DE 000 566 480 9	0	13,146,019	0 %	8.99 %
Total	13,146,019		8.99 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
				%
		Total		%

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
					%
			Total		%

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least held 3% or more)	% of voting rights through instruments (if at least held 5% or more)	Total of both (if at least held 5% or more)
Novo Nordisk Fonden	%	%	%
Novo A/S	8.99 %	0 %	8.99 %

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting:	% (equals voting rights)

10. Other explanatory remarks:

14.02.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Evotec AG
	Manfred Eigen Campus / Essener Bogen 7
	22419 Hamburg
	Germany
Internet:	www.evotec.com

End of News DGAP News Service